Delivery Order SPE2DB22D3301-SPE2DB26FX3LA
- Not listed
- The Defense Logistics Agency awarded a $6,405.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 ml dosage. This is a non-set-aside, competitively awarded contract with a completion date of September 29, 2025, and performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $4,843.93 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The contract represents a single delivery order...
- The Defense Logistics Agency awarded a $9,257.14 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL. This non-competitive, competitively awarded contract is structured as a firm fixed price delivery order with a completion date of July 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its pharmaceutical distribution...
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,510.60 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL on June 3, 2025, with performance in Conshohocken, Pennsylvania. This is a firm fixed price, non-set-aside contract with a completion date of June 4, 2025. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency Medical Supply Chain awarded a $17,277.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL of pharmaceutical product. The contract, awarded on June 16, 2025, with an ultimate completion date of June 17, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Humira Pen 40 mg/0.8 mL with a ceiling value of $1,132.95. This is a firm fixed-price delivery order under a non-set-aside competitive award, with ultimate completion scheduled for July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of HUMIRA (Adalimumab) pen injections, 40 mg/0.4 mL, with a ceiling value of $11,020.28. This is a firm fixed price delivery order with an ultimate completion date of October 15, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mL units. This contract represents a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and was awarded on July 14, 2025 with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,205.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of HUMIRA (Adalimumab) CF Pen 40 mg/0.4 mL. This contract was competitively awarded with no set-aside designation and is scheduled for completion by May 13, 2025. The pharmaceutical product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3LADelivery Order
The Defense Logistics Agency awarded a $11,604.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Humira (adalimumab) pre-filled pens, 40 mg/0.4 mL formulation. The contract is non-set-aside and competitively awarded, with an ultimate completion date of October 20, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this delivery order, which is issued under the company's larger Indefinite Delivery Contract (IDC) relationship with DLA Troop Support Medical. This delivery order represents a discrete transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the Defense Logistics Agency, which maintains a prime IDC valued at $999,999,999 through December 2026. AmerisourceBergen functions as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The Humira procurement supports the Department of Defense's medical supply chain requirements, with the firm fixed pricing structure providing cost certainty for this critical biopharmaceutical delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 10/17/25 |